Information Library
Hear From the Experts - Flexible outsourcing
To learn more about a particular aspect of Quintiles’ pharma services, biotech development or drug commercialization services, select a topic at left. If you’ve already specified a choice, you may narrow your search by selecting additional categories in any order. For example, for information on oncology drug development, start by selecting oncology. Then you can narrow your search to Central Lab, News Releases and Europe.
- Sort by: Most Recent
- Title
-
Why the pharmaceutical industry needs to evolve to meet its current challenges.
August 14, 2009
The industry is looking for a miracle to help it deal with the contracting drug pipeline and competition from generics. But, argues Daryl Gaugler President of Innovex, the answer lies not in divine intervention but in a different type of sales team for the future – one that is both more flexible... and more diverse. -
Knocking on a difficult door
August 14, 2009
The role of the payor in determining treatment paradigms for patients is growing globally. -
International and Specialty Podcast
August 13, 2009
Our news anchor Sian Jones talks to the principle advocates of outsourcing specialty care and multi country sales teams and meets one customer who’s already convinced. -
Geoff Garabedian
March 25, 2009
As Practice Leader for Regulatory and Quality in the U.S., Geoff combines a strong management consulting background with specific experience in the regulatory and compliance arena, including design and implementation of large-scale process, organization and technology transformations. -
Jacco Keja, Ph.D.
March 25, 2009
Jacco joined Quintiles Consulting in 2007 as Practice Leader, Market Access. Previously, Jacco was responsible for building Organon's global and local competence in Strategic and Operational Pricing, as well as expanding Health Economics and Outcomes Research. -
John Doyle, Dr. PH
March 25, 2009
John was president and a founder of Analytica International a global reimbursement, outcomes and market access consulting firm. He previously led the Oncology and Immunology Economics Research Group at Bristol-Myers Squibb. -
Adrian McKemey, Ph.D.
March 25, 2009
Adrian leads the Product Development and Commercialization consulting practice at Quintiles Global Consulting. -
Jim Featherstone, Ph.D.
March 25, 2009
Jim joined Quintiles Consulting from Wood Mackenzie, a leading business intelligence and strategy consulting services company based in the UK, where he was the Global Head of Consulting for the Pharmaceuticals and Biotechnology practice. -
Matthew Eberhart
March 25, 2009
Matt is a proven business-building executive with a strong track record of implementing successful business development initiatives for consulting healthcare companies in both North America and Europe. -
Jay Norman
March 24, 2009
President – Quintiles Consulting Jay brings 25 years of experience in the consulting industry and a strong track record of growth, most recently with Diamond Management and Technology Consultants, where he served as President and Chief Operating Officer.